Small to mid-market Target the niche size of 11-50 employees in a research services firm; potential for flexible, cost-efficient partnerships and personalized trial management services that larger CROs may not prioritize.

Clinical trial growth Leverage their involvement in genetic-based research and FDA-facing programs to present end-to-end trial support, including site management, regulatory compliance, and patient recruitment optimization.

Financial upside With reported revenue between one and ten million, position mid-tier CRO partnerships as a path to scalable volume work, offering competitive pricing models and value-based outcomes.

Talent expansion Noting hires in 2018 for trial assistant and clinical review roles suggests ongoing capacity building; propose staffing solutions, training programs, and premium project staffing to support growing trial activity.

Tech modernization Despite a broad tech stack, emphasize modern-dose trial platforms, data integration, and analytics to improve data capture, monitoring, and patient engagement, aligning with their research aims and efficiency goals.